NCT01128686View on ClinicalTrials.gov

Lamivudine(LAM) Good Responder Study

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Hepatitis B, Chronic
Interventions
OTHER

No intervention

This study is retrospective chart review

Trial Locations (1)

220-701

GSK Investigational Site, Kangwon-do

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY